SARS
How Inhaled Nitric Oxide Could Treat COVID-19
UAB announced Tuesday it will start testing inhaled nitric oxide as a treatment for COVID-19 patients. Nitric oxide was also used during the 2003 SARS pandemic and showed that it not only helped increase oxygen in patients, but also had anti-viral properties
World Awaits Results Of COVID-19 Drug Treatment Developed At UAB Center
In the search for a drug treatment for COVID-19, prime interest has centered on Remdesivir, a compound produced by Gilead Sciences that has its roots in a National Institutes of Health-funded center based at UAB.
UAB Leads a New Anti-Viral Drug Trial to Combat the Coronavirus
The University of Alabama at Birmingham is leading a new anti-viral drug trial in Wuhan, China to combat the coronavirus outbreak.
